Authors:
Franco, RF
Fagundes, MG
Meijers, JCM
Reitsma, PH
Lourenco, D
Morelli, V
Maffei, FH
Ferrari, IC
Piccinato, CE
Silva, WA
Zago, MA
Citation: Rf. Franco et al., Identification of polymorphisms in the 5 '-untranslated region of the TAFIgene: relationship with plasma TAFI levels and risk of venous thrombosis, HAEMATOLOG, 86(5), 2001, pp. 510-517
Citation: V. Morelli et Rj. Zoorob, Alternative therapies: Part II. Congestive heart failure and hypercholesterolemia (vol 62, pg 1325, 2000), AM FAM PHYS, 64(1), 2001, pp. 38-38
Citation: V. Morelli et Rj. Zoorob, Alternative therapies: Part II. Congestive heart failure and hypercholesterolemia, AM FAM PHYS, 62(6), 2000, pp. 1325-1330
Authors:
Franco, RF
Reitsma, PH
Lourenco, D
Maffei, FH
Morelli, V
Tavella, MH
Araujo, AG
Piccinato, CE
Zago, MA
Citation: Rf. Franco et al., Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis, THROMB HAEM, 81(5), 1999, pp. 676-679
Authors:
Franco, RF
Morelli, V
Lourenco, D
Maffei, FH
Tavella, MH
Piccinato, CE
Thomazini, IA
Zago, MA
Citation: Rf. Franco et al., A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease, BR J HAEM, 105(2), 1999, pp. 556-559
Authors:
Franco, R
Maffei, F
Lourenco, D
Piccinato, C
Morelli, V
Thomazini, I
Zago, M
Citation: R. Franco et al., The frequency of 844ins68 mutation in the cystathionine beta-synthase geneis not increased in patients with venous thrombosis, HAEMATOLOG, 83(11), 1998, pp. 1006-1008
Authors:
Franco, RF
Maffei, FH
Lourenco, D
Morelli, V
Thomazini, IA
Piccinato, CE
Tavella, MH
Zago, MA
Citation: Rf. Franco et al., Factor VArg(306)-> Thr (factor V Cambridge) and factor V Arg(306)-> Gly mutations in venous thrombotic disease, BR J HAEM, 103(3), 1998, pp. 888-890